ZERONDA TYLER (Interim CFO) received a stock award from VYNE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/15/2023ACC: 0001209191-23-058819
Officer· Interim CFO
Since Jun 2021
+125K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
125K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+62.50K
Price / share
—
Trade value
—
% of position
901.9%
12/13/2023
6.93K→69.43K
Total
Net shares
+62.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/13/2023 | A · Award | +62.50K | — | — | 901.9% | 6.93K | 69.43K |
| Total | +62.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
62.50K shares
Shares
+62.50K
Strike price
2.70
Held after
62.50K
Exercisable
—
12/13/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock62.50K shares | 12/13/2023 | A · Award | +62.50K | 2.70 | — | 62.50K |